Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients.
Krish PatelT A GooleyN BaileyM BaileyL HegerovaA BatchelderH HoldreadV DunleavyT DowneyJ FrisvoldS MegrathK PagariganJ SzetoJ RuedaA IslamC MareeS NyatsatsangS E BorkA LipkeD S O'MahonyT WagnerJ PulidoJ MignoneS YoussefM HartmanJ D GoldmanJ M PagelPublished in: Journal of internal medicine (2020)